Navigation Links
AlignMed's Breakthrough Garment Technology Gets a YES from the FDA!
Date:7/16/2013

SANTA ANA, Calif., July 16, 2013 /PRNewswire/ -- AlignMed, the innovative developer of wellness wear that has been scientifically proven to reduce pain and improve posture, has received U.S. Food and Drug Administration (FDA) Registration for its line of breakthrough specialty garments. AlignMed products are in an elite category of garments approved by the FDA Registration process as a Class 1 Medical Device.

The comfortable, form-fitting, non-restrictive Align garments feature patented Touch-Tension Neuroband™ technology that fires muscles and stimulates nerves to align the body's joints with each stride of the leg or movement of the hip, back, shoulder, chest and neck. This revolutionary concept has been vetted and tested by a panel of medical doctors and research clinics.

"We are thrilled to get the thumbs up," said AlignMed Founder Bill Schultz. "We've worked hard to ensure that every product we put into the market truly does what we say it does, and we're on a mission to help people move better and reduce pain through aligning the body. Our garments are proven to do just that." 

Primary applications include everyday wear for muscle balancing, joint unloading, injury prevention, and as a recovery tool for surgery or trauma to the upper and lower extremities. Computer users can wear the garments to fend off neck pain, back pain and poor posture prompted by excessive sitting and repetitive movements.

"As we age, mobility and agility are rapidly reduced by poor posture," Schultz continued. "The garments we've created are based on a scientifically-proven biomechanical approach that mimics the body's kinetic energy to help shape alignment and balance automatically without having to concentrate or think about it. It's a deceptively simple solution. And it works."

For information on AlignMed, visit www.alignmed.com.

About AlignMed
AlignMed is the creator of Align garments featuring the patented in-garment Touch-Tension Neuroband™ technology that has been scientifically proven to help people achieve better health and reduce pain through ensuring good posture, one of the most under-appreciated aspects of health and wellness. Ideal users include anyone with an active lifestyle, amateur and professional athletes, sports team managers and trainers, clinicians in orthopedics and physical therapy, and corporate wellness programs. www.alignmed.com

Media Contacts:
Rachel Reenders, KCOMM
949-294-5095
rachel@kcomm.com

Debra Buxton, AlignMed
714-352-8777
dbuxton@alignmed.com


'/>"/>
SOURCE AlignMed
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
2. Denton Vacuum Ships Breakthrough Wafer-level Optics Development System to Leading German R&D Organization
3. Breakthrough Prostate Cancer Diagnostics
4. Sony Announces Worlds First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
5. Major Breakthrough in Hepatitis C Vaccine Development
6. Latest Breakthroughs and Treatments in Spinal Cord Injury Medicine Bring Top Clinicians and Researchers Together in Las Vegas
7. DiFUSION Technologies Announces Breakthrough Medical Polymer
8. Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear Accelerator and MR Imaging
9. Breakthrough Drug Detection Kit Now Available at the Largest Drug Store Chain in USA
10. Breakthrough Drug Detection Kit Now Available At The Largest Internet Consumer Site
11. Holiday Breakthroughs -- Revolutionizing the Treatment of Cellulite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... Suite 10.2 version gives development continuity to its innovative Unified Instance Manager ... management capacity. In addition, this new version optimizes the unattended auto-dialing system ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... STAT courier ... to be a convenient service for Texas, they are expanding their presence in Dallas. ... a hiring spree that will bring new jobs to the Dallas and Forth Worth ...
Breaking Medicine News(10 mins):